The TIM-3 Alzheimer treatment embodies a groundbreaking approach that harnesses the immune system to combat Alzheimer's disease, particularly in its late-onset form, which constitutes the majority of cases.Researchers have recently highlighted the pivotal role of TIM-3, an immune checkpoint molecule, in regulating the activity of brain immune cells known as microglia.